Corneal Opacity

06/01/2015 - "Cosmetic outcomes improved in view of corneal opacity and conjunctival vascularization. "
06/01/2010 - "The medical records of 401 patients who presented for cosmetic improvement in corneal opacities between May 2004 and July 2007 were retrospectively reviewed. "
06/01/2010 - "This is the first study to investigate the causes and clinical characteristics of patients presenting for cosmetic treatment of corneal opacities rather than for functional improvement. "
06/01/2010 - "Various cosmetic interventions are available for patients with corneal opacities, and these should be individualized for the needs of each patient."
06/01/2010 - "A total of 321 of 401 eyes underwent cosmetic treatment for corneal opacities. "

03/01/2011 - "Results showed that superficial corneal excision with femtosecond laser augmented with PTK laser smoothening assisted with 0.25% sodium hyaluronate improved visual acuity and could be considered as an alternative to more invasive procedures in patients with severe corneal opacities."
10/01/2004 - "To assess superficial lamellar keratectomy augmented by excimer laser smoothening with sodium hyaluronate 0.25%, for the management of superficial corneal opacities. "
06/01/1985 - "The inadvertent injection of sodium hyaluronate (Healon) just anterior to Descemet's membrane during an extracapsular cataract extraction resulted in a corneal opacity. "
09/01/2001 - "To evaluate the ability of topical hyaluronic acid to decrease corneal opacity after excimer laser photorefractive keratectomy (PRK) in hens. "
10/01/2004 - "Automated superficial lamellar keratectomy combined with excimer laser PTK smoothening assisted by sodium hyaluronate 0.25% induces a significant improvement of corneal transparency and visual acuity in cases of corneal opacity caused by previous refractive surgery, ocular trauma, and keratitis."

06/01/1987 - "This study details, for the first time, the heterogeneity of the ophthalmologic features, specifically as pertains to the age of onset, degree and clinical course of the corneal opacities, and the retinal involvement. "
01/01/2010 - "A 10-month-old male infant, who presented with corneal opacity and nystagmus, was referred to our pediatric clinic and underwent a complete general physical and ophthalmological examination, including anterior segment and retinal evaluation with slit-lamp microscopy, an A/B ultrasonic scan, and electroretinography (ERG). "
03/01/2008 - "Retinal conditions were the commonest cause in urban populations (39.8% vs. 26.5% rural) compared with corneal opacity in rural areas (38.0% vs. 25.5% urban). "
07/03/1999 - "IDPN (0-400 mg kg-1 day-1x3 days, i.p.) caused corneal opacity and dose- and time-dependent increases in retinal GFAP, up to 26-28 fold of control values at 4 weeks post-exposure; a second peak occurred at 16 weeks. "
02/01/1994 - "These include corneal opacity, retinal vessel segmentation, pupil reaction, retinal changes and intraocular pressure. "

04/01/2008 - "Myriad lipid droplets in the extracellular matrix in the corneal stroma induce diffuse corneal opacity in a patient with apoA-I deficiency."
03/01/1998 - "In vivo turnover studies in rabbits demonstrated that the variant apoA-I was rapidly cleared from plasma compared with normal human apoA-I. Our data suggest that the Val156Glu substitution is associated with apoA-I and HDL deficiency, partial LCAT deficiency, and corneal opacities and that Val156 of apoA-I may play an important role in apoA-I function."
01/01/2004 - "A novel two nucleotide deletion in the apolipoprotein A-I gene, apoA-I Shinbashi, associated with high density lipoprotein deficiency, corneal opacities, planar xanthomas, and premature coronary artery disease."
11/01/2009 - "We report a novel apolipoprotein A-I (apoA-I) mutation identified in a 64-year-old patient with marked plasma high density lipoprotein (HDL) cholesterol (4 mg/dl) and apoA-I (5mg/dl) deficiency, prior myocardial infarction, and moderate corneal opacities. "
03/01/1998 - "We analyzed the genetic defect in a 67-year-old Japanese male patient with apolipoprotein (apo) A-I and high density lipoprotein (HDL) deficiencies, corneal opacities, and coronary artery disease. "

11/01/2014 - "Intravenous vitamin C reduced the corneal opacity size more than oral vitamin C (P = 0.043). "
11/01/2014 - " corneal opacity size decreased by 0.03 ± 0.10 in the oral vitamin C group, 0.07 ± 0.22 in the intravenous vitamin C group, and 0.02 ± 0.15 in the control group. "
11/01/2014 - "Efficacy of systemic vitamin C supplementation in reducing corneal opacity resulting from infectious keratitis."
11/01/2014 - "The objective of this study was to determine the effect of vitamin C supplementation on reducing the size of corneal opacity resulting from infectious keratitis.The"
11/01/2014 - "Intravenous vitamin C produced greater reduction in corneal opacity size in younger patients (P = 0.015) and those with a hypopyon (P = 0.036).Systemic vitamin C supplementation reduced the size of corneal opacity resulting from infectious keratitis. "

06/01/2013 - "Phosphate-containing eye drops: corneal opacity."
08/01/2010 - "The first case involved a patient who had keratitis after using antibiotic- and steroid-containing eyedrops to treat a corneal opacity that developed after repeated penetrating keratoplasty. "
01/01/2015 - "The efficacy, tolerability and safety of the extract of Solanum tuberosum sprouts (Panavir eyedrops) have been studied on the model of ophthalmic disorder in rabbits caused by herpes simplex virus (HSV) type 1. It is established that Panavir applied via 6 instillations per day for a period of days has potent therapeutic efficacy and prevents the development of gross corneal opacity in rabbits. "
05/01/2015 - "Panavir eye drops instilled 6 times daily for 8 days showed a pronounced therapeutic effect and prevented the development of severe corneal opacities. "
01/01/2013 - "Although eye drops of 0.1% of betamethasone sodium phosphate and 0.1% of hyaluronic acid ophthalmic solution were prescribed, calcific corneal opacities developed. "

01/01/1997 - "The trisomy 8 mosaic syndrome (Tr8MS), karyotype 46,XY/47,XY, +8, is a rare multisystem disorder that may be associated with corneal opacity. "
01/01/1997 - "Histopathology and molecular cytogenetics of a corneal opacity associated with the trisomy 8 mosaic syndrome (46,XY/47,XY, +8)."
01/01/1987 - "The necessity of including mosaic trisomy 8 in the differential diagnosis of such corneal opacities is illustrated by this case."
09/01/1983 - "Corneal opacities--a diagnostic feature of the trisomy 8 mosaic syndrome."
03/01/2001 - "Constitutional mosaic trisomy 8 has been associated with syndromic dysmorphology, corneal opacities, leukemias, and trophoblastic disease. "

01/01/2013 - "After 2 weeks, her vision had improved to 0.1 logarithm of the minimum angle of resolution, vessel regression was observed, and corneal opacity was significantly reduced. "
05/01/2010 - "Clinical examination under slitlamp was performed daily for 7 days to evaluate corneal opacity and vessel size evolution. "
05/01/2008 - "Clinical examination under stereoscopic microscope was performed to evaluate corneal opacity, neovascularization, vessel size and oedema. "
11/01/2011 - "The basal epithelial cells of the grafts showed the K3+/P63+/Ki67+ phenotype at postoperative month 1. In the acellular porcine corneal stroma group, there were some new vessel invasion into the peripheral cornea and mild corneal opacity. "
01/01/2012 - "The percentage of neovascularization area, length of the longest new vessel, corneal edema and corneal opacity scores were assessed. "

12/01/2014 - "Corneal opacity is mediated by the complex actions of many cytokines, growth factors, and chemokines produced by the epithelial cells, stromal cells, bone marrow-derived cells, lacrimal tissues, and nerves. "
04/01/2012 - "Our results indicate that during wound healing, epiregulin may regulate the expression of cytokines and chemokines to reduce an excessive accumulation of PMN cells, which will cause corneal opacity and persistent epithelial defects."
03/01/2012 - "TLR2 siRNA treatment improved the outcome of keratitis, which was characterized by decreased corneal opacity, less corneal perforation, suppressed PMN infiltration, reduced production of inflammatory cytokines and chemokines, and less fungal burden. "

12/01/2014 - "Corneal opacity is mediated by the complex actions of many cytokines, growth factors, and chemokines produced by the epithelial cells, stromal cells, bone marrow-derived cells, lacrimal tissues, and nerves. "
04/01/2012 - "Our results indicate that during wound healing, epiregulin may regulate the expression of cytokines and chemokines to reduce an excessive accumulation of PMN cells, which will cause corneal opacity and persistent epithelial defects."
03/01/2012 - "TLR2 siRNA treatment improved the outcome of keratitis, which was characterized by decreased corneal opacity, less corneal perforation, suppressed PMN infiltration, reduced production of inflammatory cytokines and chemokines, and less fungal burden. "

10/01/2012 - "Both the patients had reduction in the density of corneal opacity and improved vision postoperatively, which was more obvious in case 2. Except for a peripheral graft detachment that necessitated rebubbling in both cases, the operation was uneventful and the patients retained clear grafts up to 1 year after the operation. "
11/01/2003 - "To report the efficacy of corneal electrolysis for the treatment of recurrent corneal opacities at the subepithelial region or at the host-graft interface of the stroma in granular corneal dystrophy (GCD). "
11/01/2001 - "To evaluate the efficacy of 1-mm oversized corneal grafts in patients with acquired corneal opacities and extensive peripheral iridocorneal adhesions. "
07/01/2013 - "The only current treatment for corneal opacity is a corneal tissue transplant. "
04/01/2013 - "Rehabilitation of vision disabling corneal opacities: is there hope without corneal transplant?"

11/01/1999 - "Excimer laser PTK is a safe and effective procedure for the treatment of Japanese patients with superficial corneal opacity."
05/01/2001 - "To study the visual and refractive changes in patients with superficial corneal opacities after excimer laser phototherapeutic keratectomy (PTK). "
06/01/2000 - "To study the ocular surface disorder in patients with Avellino, granular, and lattice dystrophy, band keratopathy, and corneal leukoma before and after excimer laser phototherapeutic keratectomy. "
10/01/1991 - "As part of a human trial of phototherapeutic keratectomy, we performed anterior keratectomy using excimer laser 193-nm ablation on patients with superficial corneal opacities. "
10/01/2004 - "Automated superficial lamellar keratectomy augmented by excimer laser masked PTK in the management of severe superficial corneal opacities."

03/01/2015 - "[Subjective asymptomatic corneal opacity after Descemet membrane endothelial keratoplasty]."
11/01/2013 - "Persistent corneal opacity after descemet stripping automated endothelial keratoplasty suggesting inert material deposits into the interface."
01/01/2013 - "The Boston keratoprosthesis (B-KPro), currently the most commonly used artificial cornea worldwide, can provide rapid visual rehabilitation for eyes with severe corneal opacities not suitable for standard corneal transplantation. "
01/01/2013 - "Clinical evaluation of Deep Anterior Lamellar Keratoplasty (DALK) for stromal corneal opacities."
01/01/2013 - "Our techniques of keratoprosthesis effectively restore vision in patients with leukomas that cannot be treated by optical corneal grafting."

01/01/2016 - "To report results of femtosecond laser-assisted lamellar keratectomy (FLK) for corneal opacities secondary to anterior corneal dystrophies. "
01/01/2016 - "Femtosecond Laser-Assisted Lamellar Keratectomy for Corneal Opacities Secondary to Anterior Corneal Dystrophies: An Interventional Case Series."
01/01/2013 - "Although the origin of the corneal opacities was unclear, in vivo laser confocal microscopy was useful for observing microstructural abnormalities in a case of Descemet's membrane and subepithelial opacity."
06/01/2012 - "Intrastromal ablation with the femtosecond laser for treatment of corneal opacity."
08/01/2011 - "This report indicates that the FS laser may be an effective surgical tool for the treatment of patients with corneal opacity and that hyperopic shift is not of concern."

06/01/2008 - "Diode photocoagulation by using an endoscopic approach potentially offers an effective, safe, and minimally invasive surgical approach for the management of epithelial downgrowth in patients with corneal opacity."
12/01/2001 - "Frequency-doubled Nd:YAG (532 nm) laser photocoagulation appears a safe and effective means of reducing the area of corneal vascularisation in quiescent eyes with vascularised corneal opacities."
01/01/1984 - "The photocoagulation was considered to be very useful in cases with corneal scars, highly vascularised adherent leukomas, where keratoplasty stands a poor risk. "
09/01/2014 - "The boy was treated with bilateral intravitreal injections of bevacizumab (IVB) because laser photocoagulation of the retina could not be performed due to the corneal opacity. "